Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Klaus Rose

Showing results (11-20 of 46) with videos related to

Pageof 5
Sort By:
Children (Basel, Switzerland)|July 16, 2016
A New Ethical Challenge for Institutional Review Boards (IRBs)/Ethics Committees (ECs) in the Assessment of Pediatric Clinical TrialsKlaus Rose, Hans Kummer
Pharmaceutical Statistics|June 7, 2014
Drug development: EU paediatric legislation, the European Medicines Agency and its Paediatric Committee--adolescents' melanoma as a paradigmKlaus Rose, Stephen Senn
World Journal of Clinical Pediatrics|June 10, 2025
Disorders of gut-brain interaction are a new challenge of our increasingly complex society, with worldwide repercussionsEarl B Ettienne, Klaus Rose
Clinical Therapeutics|February 5, 2017
Do the European Medicines Agency Decisions Hurt Pediatric Melanoma Patients?Klaus Rose, Philip D Walson
Current Therapeutic Research, Clinical and Experimental|August 8, 2019
Are Regulatory Age Limits in Pediatric Melanoma Justified?Klaus Rose, Philip D Walson
World Journal of Clinical Pediatrics|June 10, 2025
African minors' health challenges are comparable to those in the rest of the worldEarl B Ettienne, Klaus Rose
Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology|October 27, 2015
Pediatric investigation plans for specific immunotherapy: Questionable contributions to childhood healthKlaus Rose, Matthias Volkmar Kopp
Handbook of Experimental Pharmacology|September 2, 2011
Development of paediatric medicines: concepts and principlesKlaus Rose, Oscar Della Pasqua
Paediatric Drugs|September 11, 2017
Do Paediatric Investigation Plans (PIPs) Advance Paediatric Healthcare?Klaus Rose, Philip D Walson
Children (Basel, Switzerland)|July 16, 2016
Cystic Fibrosis Treatment: A Paradigm for New Pediatric Medicines, Globalization of Drug Development and the Role of the European Medicines AgencyKlaus Rose, Michael G Spigarelli
Pageof 5

Showing results (11-20 of 46) with videos related to

Sort By:
Pageof 5
Children (Basel, Switzerland)|July 16, 2016
A New Ethical Challenge for Institutional Review Boards (IRBs)/Ethics Committees (ECs) in the Assessment of Pediatric Clinical TrialsKlaus Rose, Hans Kummer
Pharmaceutical Statistics|June 7, 2014
Drug development: EU paediatric legislation, the European Medicines Agency and its Paediatric Committee--adolescents' melanoma as a paradigmKlaus Rose, Stephen Senn
World Journal of Clinical Pediatrics|June 10, 2025
Disorders of gut-brain interaction are a new challenge of our increasingly complex society, with worldwide repercussionsEarl B Ettienne, Klaus Rose
Clinical Therapeutics|February 5, 2017
Do the European Medicines Agency Decisions Hurt Pediatric Melanoma Patients?Klaus Rose, Philip D Walson
Current Therapeutic Research, Clinical and Experimental|August 8, 2019
Are Regulatory Age Limits in Pediatric Melanoma Justified?Klaus Rose, Philip D Walson
World Journal of Clinical Pediatrics|June 10, 2025
African minors' health challenges are comparable to those in the rest of the worldEarl B Ettienne, Klaus Rose
Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology|October 27, 2015
Pediatric investigation plans for specific immunotherapy: Questionable contributions to childhood healthKlaus Rose, Matthias Volkmar Kopp
Handbook of Experimental Pharmacology|September 2, 2011
Development of paediatric medicines: concepts and principlesKlaus Rose, Oscar Della Pasqua
Paediatric Drugs|September 11, 2017
Do Paediatric Investigation Plans (PIPs) Advance Paediatric Healthcare?Klaus Rose, Philip D Walson
Children (Basel, Switzerland)|July 16, 2016
Cystic Fibrosis Treatment: A Paradigm for New Pediatric Medicines, Globalization of Drug Development and the Role of the European Medicines AgencyKlaus Rose, Michael G Spigarelli
Pageof 5